期刊文献+

霉酚酸酯对实验性1型糖尿病大鼠早期肾脏损害的保护作用研究

Preventive effect of mycophenolate mofetil on early diabetic nephropathy in a rat model
原文传递
导出
摘要 目的研究霉酚酸酯对糖尿病大鼠早期肾脏损害的保护作用,并对可能的机制进行探讨。方法雄性Wistar大鼠84只,随机分为3组:单肾切除对照组(24只),模型组(30只)和霉酚酸酯治疗组(30只)。分别于糖尿病成模后2周、4周、8周处死,观察内生肌酐清除率、24h尿微量白蛋白排泄量、肾脏病理组织学改变及巨噬细胞和淋巴细胞的浸润情况。结果模型组内生肌酐清除率增高,出现进行性微量白蛋白尿,与对照组差异有统计学意义。霉酚酸酯治疗组,内生肌酐清除率8周时明显低于模型组[(4.0263±0.8784)ml·min^-1·kg^-1vs(7.3270±2.9445)ml·min^-1·kg^-1,P〈0.05],24h尿微量白蛋白排泄量则于各时段均低于模型组(P〈0.05),肾小球基底膜增厚较模型组明显减轻,肾小球承膜区面积占肾小球面积的比值也减小.8周时肾小球区域巨噬细胞浸润较模型组减少[(4.07±2.05)cells/ges vs(7.29±2.14)cells/gcs,P〈0.05)],而对照组几乎未检测到。结论霉酚酸酯对糖尿病大鼠早期肾脏损害有保护作用,其机制可能是通过其抗炎、抗增殖作用产生。 Objective To investigate the protective effect of mycophenolate mofetil (MMF) on early stage renal lesions in experimental diabetic rats and to explore its mechanism. Methods Male Wistar rats were randomly divided into three groups after uninephrectomy: C, a control group( n =24) ; DM( n =30), diabetic rats model with streptozotocin; DM +MMF( n =30), diabetic rats treated with MMF, 10mg/ kg once daily by garage. Creatinine clearance and urinary albumin excretion were measured at 2 weeks, 4 weeks and 8 weeks after treatment. Renal pathological changes and the infiltration of macrophages and lymphocytes in the kidney were evaluated at 8 weeks. Reset Compared with DM group, urinary albumin excretion in DM + MMF group was markedly decreased at 8 weeks ( DM : 146. 2833 + 64. 29441μg/24h, vs DM + MMF :53. 59 ± 16. 3928μg/24h, P 〈0.05), so was Creatinine clearance( DM : 7. 3270 ± 2. 9445 ml · min^-1· kg^- 1 vs DM + MMF: 4. 0263 ± 0. 8784 ml · min^-1·kg^-1, P 〈0. 05). Pathohistological study revealed that MMF inhibited the diabetes-induced expansion of mesangial area and thickening of GBM. The kidneys of diabetic rats exhibited marked macrophage infiltrations at 8 weeks and MMF treatment prevented macrophage infiltrations significantly ( DM :7. 29 ± 2. 14 cells/gcs vs DM + MMF :4. 07 ± 2. 05cells/gcs, P 〈 0. 05). Conelusion MMF may prevent the progression of diabetic nephropathy through its anti-proliferative and anti-inilammatory properties.
作者 李静 李荣山
出处 《中国医师杂志》 CAS 2007年第1期54-57,共4页 Journal of Chinese Physician
关键词 霉酚酸/药理学 糖尿病 1型 Mycophenolic acid/pharmacology Diabetes mellitus, type 1 Kidney
  • 相关文献

参考文献11

  • 1Bohle A, Wehrmann M, Bogenschutz O , et al. Tbe pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathology, Research & Pratice, 1991,187 (2-3) :251-259.
  • 2Finoa C,Elyce O, David J, et al. Macrophages in mouse type 2 diabetic nephropathy:Corrolation with diabetic state and progressive renal injury.Kidney Int ,2004,65 : 116-128.
  • 3Morii T, Fujita H, Narita T, et al.Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. Journal of Diabetes & Its Complications,2003,17 ( 1 ) :11-15.
  • 4Riser BL, Cortes P, Heilig C, et al. Cyclic stretching force selectively upregulates transforming growth factor-beta isoforms in cultured rat mesangial ceils. Am J Pathol, 1996 ( 148 ) : 1915-1923.
  • 5Sude T, Osajima M. Pressure-induced expeession of monocyte chemottacrant protein-1 through activation of MAP kinase. Kidney Int ,2001 (60) :1705-1715.
  • 6Ricardo U, Clariee KF, Aria IM, et al. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int,2003 ( 63 ) : 209 -216.
  • 7Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology ,2000,47 (2-3) : 85-118.
  • 8Ruth Z, Steinmann-niggli K, Kappeler A, et al. Mycophenolip acid:a new approach to therapy of experimental mesangial proliferative glomerulonephritis. J Am Soc Nephrol, 1998,9:2055-2066.
  • 9Hauser IA ,Render L, Radeke HH,et al. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant, 1999,14( 1 ) :58-63.
  • 10Allison AC, Eugui EM. Springer Semin immunopathol, 1993,14:353- 380.

二级参考文献4

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部